title: Angiogenic factors in the perinatal period: diversity in biological functions reflected in their serum concentrations soon after birth.
abstract: These studies investigated whether serum levels of the angiogenic factors angiogenin, basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF) change soon after birth due to the elimination of the placenta and to diminished angiogenic but increased adaptational demands in extrauterine life. Also investigated was whether serum levels correlate with sex, birth weight, or mode of delivery. Serum from healthy mothers and their healthy full-term infants at birth (umbilical cord, UC), day 1 (N1) and day 4 (N4) postpartum was analyzed by enzyme immunoassays. Angiogenin levels were higher in maternal serum and rose significantly from UC to N1 and N4, possibly because of the elimination of the placenta, which produces an angiogenin inhibitor. bFGF and VEGF maternal levels were lower than fetal and neonatal ones. Although neonatal bFGF levels did not differ from fetal levels, possibly reflecting diminished angiogenesis ex utero, VEGF levels increased in neonatal serum, possibly signifying adaptational demands. Neither factor depended on sex, mode of delivery, or birth weight. Thus, significant differences from normal reference values of the studied factors might reflect ill-defined situations of the placenta and fetus/newborn serving as early diagnostic markers.
authors.affiliation: Second Department of Obstetrics and Gynecology, University of Athens, Greece.
authors.forename: A
authors.initials: A
authors.lastname: Malamitsi-Puchner
authors.forename: J
authors.initials: J
authors.lastname: Tziotis
authors.forename: E
authors.initials: E
authors.lastname: Protonotariou
authors.forename: A
authors.initials: A
authors.lastname: Sarandakou
authors.forename: G
authors.initials: G
authors.lastname: Creatsas
mesh_terms: D043925:Angiogenesis Inducing Agents / Q000097:blood* / Q000502:physiology; D036861:Delivery, Obstetric; D016228:Endothelial Growth Factors / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D016222:Fibroblast Growth Factor 2 / Q000097:blood*; D006801:Humans; D007231:Infant, Newborn / Q000097:blood*; D008222:Lymphokines / Q000097:blood*; D008297:Male; D011247:Pregnancy; D012259:Ribonuclease, Pancreatic / Q000097:blood*; D012737:Sex Factors; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D043925:Angiogenesis Inducing Agents; D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016222:Fibroblast Growth Factor 2; C046366:angiogenin; D012259:Ribonuclease, Pancreatic